![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,3

* Institute of Experimental Clinical Research and
Center for Hemophilia & Thrombosis, Department of Clinical Biochemistry, University Hospital of Aarhus/Skejby, Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark
3To whom correspondence should be addressed. E-mail: lse{at}dadlnet.dk.
Although hyperhomocysteinemia (HH) appears to be an independent risk factor for thrombosis, the pathophysiologic mechanisms seen in thrombus formation are largely unresolved. The aim of the present study was to investigate whether HH is accompanied by thrombogenic alterations as assessed by whole blood thromboelastographic profiles. Severe (111 µmol/L) and intermediate (42 µmol/L) HH were induced in two series of rats by feeding them a folate-depleted diet. Each group was compared with a separate control group. In rats suffering severe HH (n = 30), initiation of the coagulation was protracted, with a clotting time of 79.7 s (95% CI, 76.283.4) compared with 70.4 s (95% CI, 66.574.6) in controls (P = 0.001). The velocity of the propagation of coagulation was increased, reaching 0.119 mm/s (95% CI, 0.1110.127) in HH rats compared with 0.104 mm/s (95% CI, 0.0990.108) in controls (P < 0.001). The maximum clot firmness also was increased, i.e., 41.9 mm (95% CI, 40.543.4) in HH rats compared with 37.6 mm (95% CI, 36.538.7) in controls (P < 0.001). The resting thrombin-antithrombin complex concentration in plasma tended to be lower in HH rats [5.60 µg/L (95% CI, 3.768.34) than in controls [8.56 µg/L (95% CI, 6.4411.37)] (P = 0.074). In the series of rats with intermediate HH (n = 16), the changes in the whole blood coagulation profile (WBCP) were similar to those in rats with severe HH although only the prolongation of the initiation phase was significant. In conclusion, our study revealed that the WBCP was influenced by high plasma homocysteine by 1) prolonging the initiation phase, 2) increasing the velocity of the coagulation propagation and 3) increasing the maximum clot firmness. These changes in WBCP may contribute to the increased risk of thrombosis in hyperhomocysteinemic individuals.
KEY WORDS: blood coagulation folic acid deficiency homocysteine thromboelastography rats
This article has been cited by other articles:
![]() |
A. Undas, J. Brozek, M. Jankowski, Z. Siudak, A. Szczeklik, and H. Jakubowski Plasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1397 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Ebbesen and J. Ingerslev Folate Deficiency-Induced Hyperhomocysteinemia Attenuates, and Folic Acid Supplementation Restores, the Functional Activities of Rat Coagulation Factors XII, X, and II J. Nutr., August 1, 2005; 135(8): 1836 - 1840. [Abstract] [Full Text] [PDF] |
||||